ENIGMA-TRS 1 is a Phase 3 international, one-year, randomized, double-blind, placebo-controlled study in 600+ patients; 12-week study results ...
Tech Times on MSN
Iron oxide charge cascade produces rare two-vector magnetic state linked to skyrmion physics
Multi-k magnetism in iron oxide perovskites: a Kyoto University-led team used neutron diffraction to confirm that RBaFe2O6 ...
Adicet Bio initiates Phase I/II trial of ADI-212, an allogeneic gamma delta CAR-T therapy for metastatic castration-resistant ...
Magic-angle twisted bilayer graphene (TBG) exhibits superconductivity, and new research shows it remains stable even with ...
Encoded Therapeutics Inc., a clinical-stage biotechnology company developing precision genetic medicines for severe neurological disorders, today announced that new results from the POLARIS clinical ...
The Gabrail Cancer and Research Center, a PhaseWell Research site, today announced that Nashat Gabrail, M.D., has received notification from the U.S. Food and Drug Administration (FDA) that the ...
Wellbeing Magazine on MSN
Copper peptides and skin science: What GHK-Cu research actually investigates
Discover what current GHK-Cu research actually investigates, from molecular mechanisms to skin remodeling applications. Learn ...
Dilute magnetic semiconductors (DMSs) provide a platform for electrically controlling spin interactions; however, conventional systems face limited gate tunability and structural disorder. Here, we ...
Blocking microRNA-224 restores key signaling balance in smooth muscle cells, offering a promising strategy for pulmonary arterial hypertension.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results